找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: HCV and Related Liver Diseases; Kiwamu Okita (Professor and Chairman) Conference proceedings 1999 Springer-Verlag Tokyo 1999 cancer.hepati

[复制链接]
楼主: Jurisdiction
发表于 2025-3-27 00:07:55 | 显示全部楼层
Kiwamu Okita (Professor and Chairman)Introducing the therapeutic modalities recently developed in Japan
发表于 2025-3-27 04:23:57 | 显示全部楼层
http://image.papertrans.cn/h/image/420172.jpg
发表于 2025-3-27 07:18:50 | 显示全部楼层
https://doi.org/10.1007/978-4-431-68488-6cancer; hepatitis; liver; liver disease; viral hepatitis; hepatology
发表于 2025-3-27 12:21:48 | 显示全部楼层
发表于 2025-3-27 16:58:15 | 显示全部楼层
发表于 2025-3-27 21:18:59 | 显示全部楼层
发表于 2025-3-28 00:07:53 | 显示全部楼层
发表于 2025-3-28 03:53:45 | 显示全部楼层
,Randomized Controlled Trial of Lymphoblastoid Interferon-α for Chronic Hepatitis C; Early Disappearase (ALT) levels and disappearance of hepatitis C virus (HCV) from serum continues for several years and probably permanently after IFN. Such a response is called sustained response, and has been thought to benefit the prognosis of the patients.
发表于 2025-3-28 08:36:45 | 显示全部楼层
发表于 2025-3-28 13:34:01 | 显示全部楼层
mposium on Liver Disease, meeting in December 1998 and attended by leading hepatologists and virologists. Collected in this volume are the papers from the symposium, providing a valuable resource for hepatologists, gastroenterologists, and others working to understand and treat viral hepatitis.978-4-431-68490-9978-4-431-68488-6
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-19 01:23
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表